Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10004 | 31529394 | Obes Surg | Non-Alcoholic Fatty Liver Disease Is Associated with Impairment of Ejection Fraction Among Individuals with Obesity Undergoing Bariatric Surgery: Results of a Cross-Sectional Study. | 2020 | Details |
| A10005 | 31528301 | Gastroenterol Hepatol Bed Bench | Investigating the impact of eight weeks of aerobic and resistance training on blood lipid profile in elderly with non-alcoholic fatty liver disease: a randomized clinical trial. | 2019 | Details |
| A10006 | 31528245 | World J Hepatol | Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. | 2019 | Details |
| A10007 | 31527322 | J Atheroscler Thromb | Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults. | 2019 | Details |
| A10008 | 31526774 | Clin Chim Acta | Circulating ectodysplasin A is a potential biomarker for nonalcoholic fatty liver disease. | 2019 | Details |
| A10009 | 31526528 | J Pediatr | The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy. | 2019 | Details |
| A10010 | 31526254 | Radiology | Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment. | 2019 | Details |
| A10012 | 31524771 | Eur J Gastroenterol Hepatol | The interaction between current smoking and hemoglobin on the risk of advanced fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2020 | Details |
| A10013 | 31524533 | Expert Opin Investig Drugs | Multi-drug approaches to NASH: what's in the development pipeline? | 2019 | Details |
| A10014 | 31523999 | Expert Opin Investig Drugs | Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A10015 | 31523515 | PeerJ | Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice. | 2019 | Details |
| A10016 | 31523513 | PeerJ | Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus. | 2019 | Details |
| A10017 | 31523443 | BMJ Open Gastroenterol | Associations of chronic diarrhoea with non-alcoholic fatty liver disease and obesity-related disorders among US adults. | 2019 | Details |
| A10018 | 31523440 | BMJ Open Gastroenterol | Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. | 2019 | Details |
| A10019 | 31523414 | Ther Adv Chronic Dis | n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse model. | 2019 | Details |
| A10020 | 31522189 | Am J Case Rep | Sugar and the Mosaic of Autoimmunity. | 2019 | Details |
| A10021 | 31521875 | Eur J Radiol | MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A10023 | 31521175 | Lipids Health Dis | Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities. | 2019 | Details |
| A10024 | 31520816 | J Nutr Biochem | Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy. | 2019 | Details |
| A10027 | 31520549 | Fundam Clin Pharmacol | Tanshinone IIA reduces palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 liver cells. | 2019 | Details |
| A10030 | 31519174 | BMC Complement Altern Med | Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells. | 2019 | Details |
| A10031 | 31519114 | Expert Opin Investig Drugs | GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A10032 | 31519069 | Liver Int | PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels. | 2019 | Details |
| A10033 | 31518646 | J Hepatol | A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. | 2019 | Details |
| A10034 | 31518481 | Liver Int | Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography. | 2019 | Details |
| A10035 | 31518478 | Liver Transpl | Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience. | 2019 | Details |
| A10036 | 31517837 | Medicine (Baltimore) | Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer. | 2019 | Details |
| A10037 | 31517638 | Am J Gastroenterol | Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels. | 2019 | Details |
| A10038 | 31517325 | J Gastrointestin Liver Dis | Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease. | 2019 | Details |
| A10039 | 31517324 | J Gastrointestin Liver Dis | Effects of Dietary Intervention on Gut Microbiota and Metabolic-Nutritional Profile of Outpatients with Non-Alcoholic Steatohepatitis: a Randomized Clinical Trial. | 2019 | Details |
| A10040 | 31517316 | J Gastrointestin Liver Dis | Combination of non-invasive fibrosis tests: a solution for the prediction of advanced fibrosis in non-alcoholic fatty liver disease? | 2019 | Details |
| A10041 | 31516268 | J Clin Exp Hepatol | Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges. | 2019 | Details |
| A10042 | 31516267 | J Clin Exp Hepatol | Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How? | 2019 | Details |
| A10043 | 31516266 | J Clin Exp Hepatol | Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective. | 2019 | Details |
| A10044 | 31516265 | J Clin Exp Hepatol | Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective. | 2019 | Details |
| A10045 | 31515740 | Hepatol Int | Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study. | 2019 | Details |
| A10046 | 31514755 | BMC Pediatr | Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV. | 2019 | Details |
| A10047 | 31514484 | Genes (Basel) | Identifying Interaction Clusters for MiRNA and MRNA Pairs in TCGA Network. | 2019 | Details |
| A10048 | 31514105 | Cytokine | Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2019 | Details |
| A10049 | 31514051 | Redox Biol | Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function. | 2019 | Details |
| A10050 | 31514003 | Chemosphere | Transcriptome analysis in normal human liver cells exposed to 2, 3, 3', 4, 4', 5 - Hexachlorobiphenyl (PCB 156). | 2019 | Details |
| A10051 | 31512431 | Adv Gerontol | [The effect of high-dose metformin on the metabolic parameters and functional state of the liver of agouti-mice with the melanocortin obesity.] | 2019 | Details |
| A10052 | 31512278 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study. | 2019 | Details |
| A10053 | 31510105 | Cells | New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease. | 2019 | Details |
| A10054 | 31510077 | Nutrients | A Low Iron Diet Protects from Steatohepatitis in a Mouse Model. | 2019 | Details |
| A10055 | 31510030 | Metabolites | Nicotinamide and NAFLD: Is There Nothing New Under the Sun? | 2019 | Details |
| A10056 | 31506976 | Hepatology | Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. | 2020 | Details |
| A10057 | 31506634 | Lab Invest | Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH. | 2019 | Details |
| A10058 | 31506421 | Exp Mol Med | Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. | 2019 | Details |
| A10059 | 31505904 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children. | 2019 | Details |
| A10060 | 31505802 | Nutrients | Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding-A Review of Rodent Models. | 2019 | Details |
| A10062 | 31505462 | J Endocrinol | Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH. | 2019 | Details |
| A10063 | 31505325 | Redox Biol | Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. | 2019 | Details |
| A10064 | 31505261 | Biochim Biophys Acta Mol Cell Biol Lipids | Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures. | 2019 | Details |
| A10065 | 31505040 | Hepatology | Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis. | 2020 | Details |
| A10066 | 31504822 | Nutr Rev | Role of fruit juice in achieving the 5-a-day recommendation for fruit and vegetable intake. | 2019 | Details |
| A10067 | 31504710 | J Nutr | Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. | 2020 | Details |
| A10068 | 31503515 | Am J Physiol Endocrinol Metab | HDL flux is higher in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10071 | 31503268 | Food Funct | Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis. | 2019 | Details |
| A10073 | 31501836 | Food Funct | High-fat diet induces mouse liver steatosis with a concomitant decline in energy metabolism: attenuation by eicosapentaenoic acid (EPA) or hydroxytyrosol (HT) supplementation and the additive effects upon EPA and HT co-administration. | 2019 | Details |
| A10074 | 31500354 | Cells | Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy. | 2019 | Details |
| A10075 | 31499676 | Math Biosci Eng | Quantitative analysis of non-alcoholic fatty liver in rats via combining multiple ultrasound parameters. | 2019 | Details |
| A10076 | 31497874 | Br J Pharmacol | Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A10077 | 31497747 | Hepatol Commun | Twitter As a Noninvasive Bio-Marker for Trends in Liver Disease. | 2019 | Details |
| A10078 | 31497742 | Hepatol Commun | Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance. | 2019 | Details |
| A10079 | 31497458 | Cureus | Macro-aspartate Aminotransferase: Misleading Finding in a Patient with Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10080 | 31496904 | J Med Biochem | Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population. | 2019 | Details |
| A10081 | 31496615 | World J Gastroenterol | Methionine adenosyltransferases in liver cancer. | 2019 | Details |
| A10082 | 31496048 | Physiol Rep | Dipeptidyl peptidase-4 inhibitors and aerobic exercise synergistically protect against liver injury in ovariectomized rats. | 2019 | Details |
| A10083 | 31495973 | Hepatol Res | Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitis. | 2019 | Details |
| A10084 | 31494259 | Alcohol | Overexpression of MHCII by hepatocytes in alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH) and normal controls. | 2019 | Details |
| A10085 | 31493478 | Life Sci | Strength training reduces lipid accumulation in liver of obese Wistar rats. | 2019 | Details |
| A10086 | 31493428 | Hum Pathol | Pathology of liver disease: advances in the last 50 years. | 2019 | Details |
| A10087 | 31493247 | Hormones (Athens) | Selenium and selenoprotein P in nonalcoholic fatty liver disease. | 2019 | Details |
| A10088 | 31492960 | Sci Rep | Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. | 2019 | Details |
| A10090 | 31491949 | Int J Mol Sci | Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis. | 2019 | Details |
| A10091 | 31491605 | Ecotoxicol Environ Saf | Mono-2-ethylhexyl phthalate (MEHP) promoted lipid accumulation via JAK2/STAT5 and aggravated oxidative stress in BRL-3A cells. | 2019 | Details |
| A10092 | 31491513 | Int J Biol Macromol | MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. | 2019 | Details |
| A10093 | 31489674 | J Food Biochem | Dietary chia seeds (Salvia hispanica) improve acute dyslipidemia and steatohepatitis in rats. | 2019 | Details |
| A10094 | 31488477 | BMJ Open | Association between nut intake and non-alcoholic fatty liver disease risk: a retrospective case-control study in a sample of Chinese Han adults. | 2019 | Details |
| A10095 | 31488310 | Rev Gastroenterol Mex (Engl Ed) | Extrahepatic complications of non-alcoholic fatty liver disease: Its impact beyond the liver. | 2019 | Details |
| A10096 | 31488034 | Am J Chin Med | Rhus verniciflua and Eucommia ulmoides Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK Activation. | 2019 | Details |
| A10097 | 31485568 | Mayo Clin Proc Innov Qual Outcomes | A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk. | 2019 | Details |
| A10098 | 31485221 | Int J Endocrinol | Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10099 | 31484323 | Nutrients | Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. | 2019 | Details |
| A10100 | 31484207 | J Periodontol | Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study. | 2019 | Details |
| A10101 | 31484072 | Cell Rep | Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis. | 2019 | Details |
| A10102 | 31484042 | Life Sci | LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease. | 2019 | Details |
| A10103 | 31483669 | J Proteome Res | High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway. | 2019 | Details |
| A10104 | 31483122 | Croat Med J | Association between rs2303861 polymorphism in CD82 gene and non-alcoholic fatty liver disease: a preliminary case-control study. | 2019 | Details |
| A10105 | 31482785 | Am J Trop Med Hyg | Opisthorchis viverrini Infection Augments the Severity of Nonalcoholic Fatty Liver Disease in High-Fat/High-Fructose Diet-Fed Hamsters. | 2019 | Details |
| A10106 | 31482741 | Arch Physiol Biochem | Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices? | 2019 | Details |
| A10107 | 31482482 | Obes Surg | Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting. | 2020 | Details |
| A10108 | 31482382 | Endocrine | Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis. | 2019 | Details |
| A10109 | 31481896 | Front Physiol | Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis. | 2019 | Details |
| A10110 | 31480575 | Biomolecules | Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice. | 2019 | Details |
| A10111 | 31479572 | Liver Int | Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults. | 2019 | Details |
| A10112 | 31479282 | Expert Opin Drug Saf | The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis. | 2019 | Details |
| A10113 | 31478458 | Mol Imaging | PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A10114 | 31477797 | Eur J Clin Nutr | Association between habitual yogurt consumption and newly diagnosed non-alcoholic fatty liver disease. | 2019 | Details |